RNAi 在大腸癌基因治療中的應用策略和展望_《中國普外基礎與臨床雜志》

作者：

呂偉 , 張超

第三軍醫大學西南醫院普通外科（重慶400038）;

關鍵詞：

RNA干擾大腸癌基因治療

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

【摘要】目的探討RNA干擾(RNA interference， RNAi)技術在大腸癌基因治療研究中的應用。
方法復習近幾年的相關文獻并進行綜述。
結果 RNAi能夠高效特異地沉默同源基因表達，可在大腸癌發生、發展多個環節發揮重要作用。
結論 RNAi技術為大腸癌基因治療研究開辟了新的途徑。

引用本文： 呂偉,張超. RNAi 在大腸癌基因治療中的應用策略和展望. 中國普外基礎與臨床雜志, 2005, 12(6): 637-640. doi: 復制

1.	Kerr D. Clinical development of gene therapy for colorectal cancer [J]. Nat Rev Cancer, 2003; 3(8)615.
2.	Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans [J]. Nature， 1998; 391(6669)806.
3.	Zamore PD. RNA interference: listening to the sound of silence [J]. Nat Struct Biol， 2001; 8(9)746.
4.	Hammond SM, Bernstein E, Beach D, et al. An RNAdirected nuclease mediates posttranscriptional gene silencing in Drosophila cells [J]. Nature， 2000; 404(6775)293.
5.	Bernstein E, Caudy AA, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference [J]. Nature， 2001; 409(6818)363.
6.	Yang D, Lu H, Erickson JW. Evidence that processed small dsRNAs may mediate sequencespecific mRNA degradation during RNAi in Drosophila embryos [J]. Curr Biol， 2000; 10(19)1191.
7.	Kawasaki H, Taira K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAimediated gene silencing in the cytoplasm of human cells [J]. Nucleic Acids Res， 2003; 31(2)700.
8.	Caplen NJ, Fleenor J, Fire A, et al. dsRNAmediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference [J]. Gene， 2000; 252(1-2)95.
9.	Zamore PD, Tuschl T, Sharp PA, et al. RNAi: doublestranded RNA directs the ATPdependent cleavage of mRNA at 21 to 23 nucleotide intervals [J]. Cell， 2000; 101(1)25.
10.	Shen WG. RNA interference and its current application in mammals [J]. Chin Med J (Engl)， 2004; 117(7)1084.
11.	Paul CP, Good PD, Winer I, et al. Effective expression of small interfering RNA in human cells [J]. Nat Biotechnol， 2002; 20(5)505.
12.	Finkelstein SD, Przygodzki R, Pricolo VE, et al. Prediction of Biologic Aggressiveness in Colorectal Cancer by p53/Kras2 Topographic Genotyping [J]. Mol Diagn， 1996; 1(1)5.
13.	Martinez LA, Naguibneva I, Lehrmann H, et al. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways [J]. Proc Natl Acad Sci USA， 2002; 99(23)14849.
14.	Yin JQ, Gao J, Shao R, et al. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth [J]. J Exp Ther Oncol， 2003; 3(4)194.
15.	Takeda A, Shimada H, Imaseki H, et al. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers [J]. Oncol Rep， 2000; 7(2)333.
16.	Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics [J]. Cancer Res， 2004; 64(10)3365.
17.	Nagy P, ArndtJovin DJ, Jovin TM. Small interfering RNAs suppress the expression of endogenous and GFPfused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1overexpressing cells [J]. Exp Cell Res， 2003; 285(1)39.
18.	Zhang L, Yang N, MohamedHadley A, et al. Vectorbased RNAi, a novel tool for isoformspecific knockdown of VEGF and antiangiogenesis gene therapy of cancer [J]. Biochem Biophys Res Commun， 2003; 303(4)1169.
19.	Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi) [J]. FEBS Lett， 2003; 545(2-3)144.
20.	Lum L, Yao S, Mozer B, et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells [J]. Science， 2003; 299(5615)2039.
21.	Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against betacatenin inhibit the in vitro and in vivo growth of colon cancer cells [J]. Clin Cancer Res， 2003; 9(4)1291.
22.	方向明，于皆平，羅和生. 大腸癌hTERT和P16表達與端粒酶活性的在系 [J]. 世界華人消化雜志， 2002； 10（1）12.
23.	Horikawa I, Cable PL, Mazur SJ, et al. Downstream Eboxmediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression [J]. Mol Biol Cell， 2002; 13(8)2585.
24.	Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression [J]. Cancer Lett， 2003; 190(2)125.
25.	Matsukura S, Jones PA, Takai D. Establishment of conditional vectors for hairpin siRNA knockdowns [J]. Nucleic Acids Res， 2003; 31(15)e77.

1. Kerr D. Clinical development of gene therapy for colorectal cancer [J]. Nat Rev Cancer, 2003; 3(8)615.
2. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans [J]. Nature， 1998; 391(6669)806.
3. Zamore PD. RNA interference: listening to the sound of silence [J]. Nat Struct Biol， 2001; 8(9)746.
4. Hammond SM, Bernstein E, Beach D, et al. An RNAdirected nuclease mediates posttranscriptional gene silencing in Drosophila cells [J]. Nature， 2000; 404(6775)293.
5. Bernstein E, Caudy AA, Hammond SM, et al. Role for a bidentate ribonuclease in the initiation step of RNA interference [J]. Nature， 2001; 409(6818)363.
6. Yang D, Lu H, Erickson JW. Evidence that processed small dsRNAs may mediate sequencespecific mRNA degradation during RNAi in Drosophila embryos [J]. Curr Biol， 2000; 10(19)1191.
7. Kawasaki H, Taira K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAimediated gene silencing in the cytoplasm of human cells [J]. Nucleic Acids Res， 2003; 31(2)700.
8. Caplen NJ, Fleenor J, Fire A, et al. dsRNAmediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference [J]. Gene， 2000; 252(1-2)95.
9. Zamore PD, Tuschl T, Sharp PA, et al. RNAi: doublestranded RNA directs the ATPdependent cleavage of mRNA at 21 to 23 nucleotide intervals [J]. Cell， 2000; 101(1)25.
10. Shen WG. RNA interference and its current application in mammals [J]. Chin Med J (Engl)， 2004; 117(7)1084.
11. Paul CP, Good PD, Winer I, et al. Effective expression of small interfering RNA in human cells [J]. Nat Biotechnol， 2002; 20(5)505.
12. Finkelstein SD, Przygodzki R, Pricolo VE, et al. Prediction of Biologic Aggressiveness in Colorectal Cancer by p53/Kras2 Topographic Genotyping [J]. Mol Diagn， 1996; 1(1)5.
13. Martinez LA, Naguibneva I, Lehrmann H, et al. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways [J]. Proc Natl Acad Sci USA， 2002; 99(23)14849.
14. Yin JQ, Gao J, Shao R, et al. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth [J]. J Exp Ther Oncol， 2003; 3(4)194.
15. Takeda A, Shimada H, Imaseki H, et al. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers [J]. Oncol Rep， 2000; 7(2)333.
16. Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics [J]. Cancer Res， 2004; 64(10)3365.
17. Nagy P, ArndtJovin DJ, Jovin TM. Small interfering RNAs suppress the expression of endogenous and GFPfused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1overexpressing cells [J]. Exp Cell Res， 2003; 285(1)39.
18. Zhang L, Yang N, MohamedHadley A, et al. Vectorbased RNAi, a novel tool for isoformspecific knockdown of VEGF and antiangiogenesis gene therapy of cancer [J]. Biochem Biophys Res Commun， 2003; 303(4)1169.
19. Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi) [J]. FEBS Lett， 2003; 545(2-3)144.
20. Lum L, Yao S, Mozer B, et al. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells [J]. Science， 2003; 299(5615)2039.
21. Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against betacatenin inhibit the in vitro and in vivo growth of colon cancer cells [J]. Clin Cancer Res， 2003; 9(4)1291.
22. 方向明，于皆平，羅和生. 大腸癌hTERT和P16表達與端粒酶活性的在系 [J]. 世界華人消化雜志， 2002； 10（1）12.
23. Horikawa I, Cable PL, Mazur SJ, et al. Downstream Eboxmediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression [J]. Mol Biol Cell， 2002; 13(8)2585.
24. Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression [J]. Cancer Lett， 2003; 190(2)125.
25. Matsukura S, Jones PA, Takai D. Establishment of conditional vectors for hairpin siRNA knockdowns [J]. Nucleic Acids Res， 2003; 31(15)e77.

《中國普外基礎與臨床雜志》

RNAi 在大腸癌基因治療中的應用策略和展望

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國普外基礎與臨床雜志》

RNAi 在大腸癌基因治療中的應用策略和展望

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料